Evogene Q3 Revenue Grows 208% YoY, Here Are The Details
Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) Q3 2022 revenues were $466,000, a 208% increase in comparison to $151,000 in the same period of the previous year and were primarily due to revenues recognized per the collaboration agreement of Evogene's subsidiary AgPlen
